Rein Therapeutics Inc (RNTX) — Financial Flexibility Index
Rein Therapeutics Inc (RNTX) has a Financial Flexibility Index of -0.23x as of March 2026. Free cash flow of $-3.42 Million (operating CF $-3.42 Million minus capex $0.00) represents 0% of total liabilities ($14.70 Million). Check Rein Therapeutics Inc (RNTX) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rein Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Rein Therapeutics Inc across 11 annual periods. See how liquid is Rein Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rein Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Rein Therapeutics Inc. For the full company profile including market capitalisation, see Rein Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.67x | $-19.36 Million | $-19.36 Million | $7.24 Million | ▼ -78.1% |
| 2024 | -1.50x | $-22.29 Million | $-22.29 Million | $14.85 Million | ▼ -651.3% |
| 2023 | -0.20x | $-19.81 Million | $-19.81 Million | $99.12 Million | ▲ +97.3% |
| 2022 | -7.35x | $-24.86 Million | $-24.86 Million | $3.38 Million | ▼ -42.5% |
| 2021 | -5.16x | $-23.60 Million | $-23.75 Million | $4.58 Million | ▼ -5.2% |
| 2020 | -4.90x | $-20.47 Million | $-20.48 Million | $4.18 Million | ▼ -94.0% |
| 2019 | -2.52x | $-26.32 Million | $-26.47 Million | $10.43 Million | ▼ -15.1% |
| 2018 | -2.19x | $-23.50 Million | $-27.93 Million | $10.71 Million | ▲ +47.4% |
| 2017 | -4.17x | $-20.39 Million | $-20.53 Million | $4.89 Million | ▼ -3615.7% |
| 2016 | -0.11x | $-15.01 Million | $-15.01 Million | $133.83 Million | ▲ +3.2% |
| 2015 | -0.12x | $-11.62 Million | $-11.71 Million | $100.26 Million | — |